Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Archives of Biochemistry and Biophysics

• Publication date

  1993-02-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1006/ABBI.1993.1112PMID 8442665
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alzheimer paired helical filaments: Bulk isolation, solubility, and protein composition

  2004cited by this paper
• The comparative immunoreactivities of brain amyloids in Alzheimer's disease and scrapie

  2004cited by this paper
• Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

  1992cited by this paper
• Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments

  1992cited by this paper
• Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

  1992cited by this paper
• In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity.

  1991cited by this paper
• The molecular pathology of Alzheimer's disease.

  1991cited by this paper
• Accumulation of amyloid precursor fragment in Alzheimer plaques.

  1991cited by this paper
• Distribution and activity of alternatively spliced Alzheimer amyloid peptide precursor and scrapie PrP mRNAs on rat brain polysomes.

  1991cited by this paper
• Effects of injected Alzheimer beta-amyloid cores in rat brain.

  1991cited by this paper
• An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.

  1991cited by this paper
• Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease.

  1991cited by this paper
• Beta-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons.

  1991cited by this paper
• Amyloid-beta peptide, substance P, and bombesin bind to the serpin-enzyme complex receptor.

  1991cited by this paper
• Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

  1991cited by this paper
• Purification and tissue level of the beta-amyloid peptide precursor of rat brain.

  1991cited by this paper
• A computer program (COMPOST) for predicting mass spectrometric information from known amino acid sequences

  1991cited by this paper
• Alzheimer's β‐Amyloid Protein Is Covalently Modified when Dissolved in Formic Acid

  1990cited by this paper
• Cleavage of amyloid beta peptide during constitutive processing of its precursor.

  1990cited by this paper
• Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein

  1990cited by this paper
• Sequencing of peptides by tandem mass spectrometry and high-energy collision-induced dissociation.

  1990cited by this paper
• Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing.

  1990cited by this paper
• The PreA4(695) precursor protein of Alzheimer's disease A4 amyloid is encoded by 16 exons.

  1989cited by this paper
• Alzheimer's disease: Mismatch between amyloid plaques and neuritic plaques

  1989cited by this paper
• The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid.

  1989cited by this paper
• The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II

  1989cited by this paper
• Amyloid beta protein enhances the survival of hippocampal neurons in vitro.

  1989cited by this paper
• Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor.

  1989cited by this paper
• Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons.

  1988cited by this paper
• Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging.

  1988cited by this paper
• A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors

  1988cited by this paper
• Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease

  1988cited by this paper
• Differences Between Vascular and Plaque Core Amyloid in Alzheimer's Disease

  1988cited by this paper
• Neuritic Plaque Amyloid in Alzheimer's Disease Is Highly Racemized

  1988cited by this paper
• Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity

  1988cited by this paper
• Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease.

  1988cited by this paper
• Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides.

  1987cited by this paper
• The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

  1987cited by this paper
• Amyloid Angiopathy of Alzheimer's Disease: Amino Acid Composition and Partial Sequence of a 4,200‐Dalton Peptide Isolated from Cortical Microvessels

  1987cited by this paper
• Isolation of Low‐Molecular‐Weight Proteins from Amyloid Plaque Fibers in Alzheimer's Disease

  1986cited by this paper
• Isolation and Partial Characterization of Neurofibrillary Tangles and Amyloid Plaque Core in Alzheimer's Disease: Immunohistological Studies

  1986cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related.

  1985cited by this paper
• Amino acid analysis by reverse-phase high-performance liquid chromatography: precolumn derivatization with phenylisothiocyanate.

  1984cited by this paper
• Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.

  1984cited by this paper
• A gas-liquid solid phase peptide and protein sequenator.

  1981cited by this paper

• A Question of Origins: Non-neuronal Sources of Amyloid-β.

  2026cites this paper
• Biophysical insights into the molecular mechanisms of beta amyloid aggregation and its toxic effects in Alzheimer’s disease

  2025cites this paper
• Post‐Translational Modifications Distinguish Amyloid‐β Isoforms in Cerebral Amyloid Angiopathy and Alzheimer's Disease

  2025cites this paper
• The role of redox-active iron, copper, manganese, and redox-inactive zinc in toxicity, oxidative stress, and human diseases

  2025cites this paper
• Post-translational modifications distinguish amyloid-β isoform patterns extracted from vascular deposits and parenchymal plaques

  2025cites this paper
• Isomerized Aβ in the brain can distinguish the status of amyloidosis in the Alzheimer’s Disease spectrum

  2025influential citation
• Plasma Biomarkers for Cerebral Amyloid Angiopathy and Implications for Amyloid-Related Imaging Abnormalities: A Comprehensive Review

  2025cites this paper
• Chemical imaging delineates Aβ plaque polymorphism across the Alzheimer’s disease spectrum

  2025cites this paper
• Inducers and modulators of protein aggregation in Alzheimer's disease - Critical tools for understanding the foundations of aggregate structures

  2025cites this paper
• Deciphering the role of APOE in cerebral amyloid angiopathy: from genetic insights to therapeutic horizons

  2025cites this paper
• Antioxidant, anticancer, and anti-inflammatory potential of carotenoids produced by green microalga Asterarcys quadricellulare (K.Behre) E. Hegewald & A. W. F. Schmidt

  2025cites this paper
• Current understanding of the microscopic effects of intrinsically disordered protein aggregates on the interfacial solvent properties

  2025cites this paper
• Extracellular Vesicles and Purinergic Signaling in Alzheimer’s Disease—Joining Forces for Novel Therapeutic Approach

  2025cites this paper
• West Nile virus non-structural protein 1 promotes amyloid Beta deposition and neurodegeneration.

  2025cites this paper
• Amyloid beta 1‐40 and 1‐42 fibril ratios and maturation level cause conformational differences with minimal impact on autophagy and cytotoxicity

  2024cites this paper
• Dual-ligand fluorescence microscopy enables chronological and spatial histological assignment of distinct amyloid-β deposits

  2024cites this paper
• Loss of TREM2 diminishes CAA despite an overall increase of amyloid load in Tg‐SwDI mice

  2024cites this paper
• Structure of cytotoxic amyloid oligomers generated during disaggregation

  2024cites this paper
• Zinc utilization by microglia in Alzheimer’s disease

  2024cites this paper
• Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities

  2024cites this paper
• Amino‐terminally elongated Aβ peptides are generated by the secreted metalloprotease ADAMTS4 and deposit in a subset of Alzheimer's disease brains

  2024cites this paper
• Loss of Direct Vascular Contact to Astrocytes in the Hippocampus as an Initial Event in Alzheimer’s Disease. Evidence from Patients, In Vivo and In Vitro Experimental Models

  2024cites this paper
• Thiophene-Based Ligands for Specific Assignment of Distinct Aβ Pathologies in Alzheimer's Disease

  2024cites this paper
• Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice

  2024cites this paper
• Identification of isoAsp7-Aβ as a major Aβ variant in Alzheimer’s disease, dementia with Lewy bodies and vascular dementia

  2024cites this paper
• Towards early diagnosis and screening of Alzheimer’s disease using frequency locked whispering gallery mode microtoroids

  2024cites this paper
• The duality of amyloid-β: its role in normal and Alzheimer’s disease states

  2024cites this paper
• Aβ38 and Aβ43 do not differentiate between Alzheimer's disease and cerebral amyloid angiopathy

  2024cites this paper
• Aggregation Dynamics of a 150 kDa Aβ42 Oligomer: Insights from Cryo Electron Microscopy and Multimodal Analysis

  2024cites this paper
• Towards Early Diagnosis and Screening of Alzheimer’s Disease Using Frequency Locked Whispering Gallery Mode Microtoroid Biosensors

  2024cites this paper
• Aggregation dynamics of a 150 kDa Aβ42 oligomer: Insights from cryo electron microscopy and multimodal analysis

  2024cites this paper
• Multimodal beneficial effects of BNN27, a nerve growth factor synthetic mimetic, in the 5xFAD mouse model of Alzheimer’s disease

  2024cites this paper
• Advancements and Challenges in Preclinical Study Models of Neurodegenerative Brain Diseases: Alzheimer's and Parkinson's Diseases

  2024cites this paper
• Vascular Heparan Sulfate and Amyloid-β in Alzheimer’s Disease Patients

  2024cites this paper
• Glymphatic Pathway in Sporadic Cerebral Small Vessel Diseases: From Bench to Bedside.

  2023cites this paper
• Cellular response to β‐amyloid neurotoxicity in Alzheimer's disease and implications in new therapeutics

  2023cites this paper
• Advances in sample preparation and HPLC–MS/MS methods for determining amyloid-β peptide in biological samples: a review

  2023cites this paper
• Border-associated macrophages promote cerebral amyloid angiopathy and cognitive impairment through vascular oxidative stress

  2023cites this paper
• Pharmacological modulation of HIF-1 in the treatment of neuropsychiatric disorders

  2023cites this paper
• Anti-Amyloid Therapy, AD, and ARIA: Untangling the Role of CAA

  2023cites this paper
• The stability and dynamics of the Aβ40/Aβ42 interlaced mixed fibrils

  2023cites this paper
• The supersaturation perspective on the amyloid hypothesis

  2023cites this paper
• Impact of Interleukin-34 on the Promotion of Bone Osteolysis and Neuroinflammation in Experimental Models of Alzheimer’S Disease

  2023cites this paper
• Border-associated macrophages promote cerebral amyloid angiopathy and cognitive impairment through vascular oxidative stress

  2023cites this paper
• IM-MS and ECD-MS/MS Provide Insight into Modulation of Amyloid Proteins Self-Assembly by Peptides and Small Molecules.

  2023cites this paper
• A Systematic Review of the Effects of Capsaicin on Alzheimer’s Disease

  2023cites this paper
• Antibodies Raised Against an Aβ Oligomer Mimic Recognize Pathological Features in Alzheimer’s Disease and Associated Amyloid-Disease Brain Tissue

  2023cites this paper
• Deciphering mechanisms of action of ACE inhibitors in neurodegeneration using Drosophila models of Alzheimer’s disease

  2023cites this paper
• Colocalization of β-Sheets and Carotenoids in Aβ Plaques Revealed with Multimodal Spatially Resolved Vibrational Spectroscopy.

  2023cites this paper
• Targeting lysyl-oxidase (LOX) may facilitate intramural periarterial drainage for the treatment of Alzheimer's disease

  2023cites this paper
• Discoveries and future significance of research into amyloid-beta/α7-containing nicotinic acetylcholine receptor (nAChR) interactions

  2023cites this paper
• EPR Studies of Aβ42 Oligomers Indicate a Parallel In-Register β-Sheet Structure

  2023cites this paper
• Intermediate Antiparallel β Structure in Amyloid β Plaques Revealed by Infrared Spectroscopic Imaging.

  2023cites this paper
• Brain Region-Specific Differences in Amyloid-β Plaque Composition in 5XFAD Mice

  2023cites this paper
• Development of an α-synuclein positron emission tomography tracer for imaging synucleinopathies.

  2023cites this paper
• Preparation and Fractionation of Heterogeneous Aβ42 Oligomers with Different Aggregation Properties.

  2023cites this paper
• Advances in amyloid-targeting monoclonal antibodies for Alzheimer’s disease: clinical and public health issues

  2023cites this paper
• Neglected N-Truncated Amyloid-β Peptide and Its Mixed Cu–Zn Complexes

  2022cites this paper
• Adenosine receptor signalling in Alzheimer’s disease

  2022cites this paper
• Cerebral Superficial Siderosis

  2022cites this paper
• Molecular Mechanism of Cyanidin-3-O-Glucoside Disassembling Aβ Fibril In Silico

  2022cites this paper
• Static and dynamic disorder in Aβ40 fibrils.

  2022cites this paper
• Pathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives

  2022cites this paper
• Alzheimer’s Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint

  2022cites this paper
• Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice

  2022cites this paper
• Identifying the role of co-aggregation of Alzheimer’s amyloid-β with amorphous protein aggregates of non-amyloid proteins

  2022cites this paper
• Chemical traits of cerebral amyloid angiopathy in familial British‐, Danish‐, and non‐Alzheimerʼs dementias

  2022cites this paper
• Key Residue for Aggregation of Amyloid-β Peptides

  2022cites this paper
• Endoplasmic reticulum stress induces Alzheimer disease‐like phenotypes in the neuron derived from the induced pluripotent stem cell with D678H mutation on amyloid precursor protein

  2022cites this paper
• Systematic Review on the Role of Lobar Cerebral Microbleeds in Cognition

  2022cites this paper
• Tripartite Relationship Among Synaptic, Amyloid, and Tau Proteins

  2021cites this paper
• Refining the amyloid β peptide and oligomer fingerprint ambiguities in Alzheimer’s disease: Mass spectrometric molecular characterization in brain, cerebrospinal fluid, blood, and plasma

  2021cites this paper
• The Potential Role of Protein Kinase R as a Regulator of Age-Related Neurodegeneration

  2021cites this paper
• The Neurovascular Unit Dysfunction in Alzheimer’s Disease

  2021cites this paper
• The Role of Cathepsin B in the Degradation of Aβ and in the Production of Aβ Peptides Starting With Ala2 in Cultured Astrocytes

  2021cites this paper
• The role of amyloid oligomers in neurodegenerative pathologies.

  2021cites this paper
• A Review of the Current Mammalian Models of Alzheimer’s Disease and Challenges That Need to Be Overcome

  2021cites this paper
• Pyroglutamate Aβ cascade as drug target in Alzheimer’s disease

  2021cites this paper
• N-Truncated Aβ Starting at Position Four—Biochemical Features, Preclinical Models, and Potential as Drug Target in Alzheimer’s Disease

  2021cites this paper
• Human cerebral vascular amyloid contains both antiparallel and parallel in-register Aβ40 fibrils

  2021cites this paper
• Current Management and Therapeutic Strategies for Cerebral Amyloid Angiopathy

  2021cites this paper
• Postmortem Neocortical 3H-PiB Binding and Levels of Unmodified and Pyroglutamate Aβ in Down Syndrome and Sporadic Alzheimer’s Disease

  2021cites this paper
• N-terminal heterogeneity of parenchymal and vascular amyloid-β deposits in Alzheimer’s disease

  2020cites this paper
• Amyloidosis is associated with thicker myelin and increased oligodendrogenesis in the adult mouse brain

  2020cites this paper
• HDL mimetic peptide 4F efficiently crosses the blood-brain barrier and modulates amyloid beta distribution between brain and plasma

  2020cites this paper
• Marine Microalgae for Potential Lutein Production

  2020cites this paper
• Correlation of pyroglutamate amyloid β and ptau Ser202/Thr205 levels in Alzheimer’s disease and related murine models

  2020cites this paper
• A Pilot Study of Urinary Exosomes in Alzheimer’s Disease

  2020cites this paper
• Prodromal Intestinal Events in Alzheimer’s Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition

  2020cites this paper
• The Isolated Brain Microvessel: A Versatile Experimental Model of the Blood-Brain Barrier

  2020cites this paper
• High-Density Lipoprotein Mimetic Peptide 4F Efficiently Crosses the Blood-Brain Barrier and Modulates Amyloid-β Distribution between Brain and Plasma

  2020cites this paper
• Differentiating Aβ40 and Aβ42 in amyloid plaques with a small molecule fluorescence probe†

  2020cites this paper
• Structural and mechanistic insights into the inhibition of amyloid-β aggregation by Aβ39-42 fragment derived synthetic peptides.

  2020cites this paper
• Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina

  2020cites this paper
• Extracellular Amyloid Deposits in Alzheimer’s and Creutzfeldt–Jakob Disease: Similar Behavior of Different Proteins?

  2020cites this paper
• Distinguishing the Effect on the Rate and Yield of Aβ42 Aggregation by Green Tea Polyphenol EGCG

  2020cites this paper
• Bicine promotes rapid formation of β-sheet-rich amyloid-β fibrils

  2020cites this paper
• Alzheimer’s disease and Down syndrome

  2020cites this paper
• A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy

  2020cites this paper
• Alzheimer's Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions.

  2020cites this paper